Search Results for

Vascular Dementia and Alzheimer’s Prevention Tips

Not all dementia shows the same course. Alzheimer’s disease usually progresses slowly, steadily – over many years. There are also rapidly deteriorating or fluctuating forms of dementia. The latter run in spurts: phases, in which the parties can think as clearly as before her illness or in early stages of the disease are sudden mood swings, and replaced by a marked decline in mental abilities. The dementia course varies with the individual.

How to Prevent Vascular Dementia and Alzheimers ?

With dementia can not be targeted to prevent, since its exact causes are not fully understood until now. By some underlying medical conditions is known that the risk of Vascular Dementia and Alzheimer’s disease increases:

• Diabetes (diabetes mellitus)
• Hypertension
• Atrial fibrillation
• Nicotine and alcohol consumption
• Previous head injury (stroke, trauma boxer)

Read more…

Incoming Search Terms :

Bulimia Nervosa Definition Overview

Bulimia nervosa, some people also known as bulimia is an eating disorder, the colloquially known as eating crushing addiction. It goes hand in hand with binge eating and then vomiting, and even disheveled abuse of drugs. These stakeholders primarily afraid of gaining weight.

In contrast to anorexia (anorexia nervosa) or binge eating disorder are affected by bulimia nervosa (usually women) is usually of normal weight. The bulimia nervosa causes range from psychological and biological factors on family obligations up to the social slimness. Bulimia also affected many people in Alabama, Colorado, Connecticut, Delaware, Arizona, llinois, Indiana, Arkansas, California, Hawaii, Florida, Idaho, Georgia, Iowa, Canada, British Columbia, Alberta and Manitoba. Bulimia is one of mental illness diseases.

Typical symptoms of bulimia nervosa are binge eating, depression) in many cases, vomiting and consequent damage (caries, electrolyte deficiency. The interested parties are trying to keep secret their eating disorder. Therefore, it is taken, on average, about five years after the first treatment attempt.

The treatment of eating crushing addiction aims to normalize eating habits. Following the underlying causes of bulimia are treated in psychotherapy. In individual cases, bulimia disease is Read more…

Incoming Search Terms :

Treatment of Lung Cancer Therapy for Healthy

The treatment of lung cancer, also known as lung cancer treatments and therapy can result in surgical removal of the tumor, chemotherapy or radiotherapy, and combinations of these treatments. The decision on which treatments are appropriate for a given individual should take into account the location and extent of the tumor and the patient’s general health.

As with other types of cancer treatment can be provided that the allegations curative (removal or eradication of cancer) or palliative (measures that are not able to cure cancer, but may reduce pain and suffering). More than one type of treatment may be prescribed. In such cases, therapy is added to enhance the effects of primary therapy is known as adjuvant therapy. An example of adjuvant treatment with chemotherapy or radiation therapy after surgery to remove a tumor, to be sure who killed the tumor cells.

Lung Cancer Surgery

Surgical removal of the tumor is usually performed for limited stage (stage I or, sometimes, phase II) and NSCLC (non-small-cell lung cancer) is the treatment against cancer that has not spread beyond the lung. Approximately 10% -35% of lung cancers can be surgically removed, but the withdrawal does not always translate into a cure, because the tumors have already spread in May and may occur at a later date. Among those who are isolated, slow-growing cancer of the lung removed, 25% to 40% are still alive five years after diagnosis. Surgery may not be possible if the cancer is near the trachea or if you have other serious diseases (like heart or lung disease) that limit their ability to tolerate surgery. The operation was performed less often because SCLC tumors are less likely to be located in an area that can be eliminated.

The surgical lung cancer procedure chosen depends on the size and location of the tumor. Surgeons must open the chest wall and may perform a lung wedge resection (removal of part of one lobe), lobectomy (removal of one lobe) or pneumonectomy (removal of an entire lung). Sometimes lymph nodes in the region of the lungs are removed (lymphadenectomy). Surgery for lung cancer is a major surgery requiring general anesthesia, hospitalization and follow-up care for weeks or months. After surgery, patients may experience difficulty breathing, shortness of breath, pain and weakness. The risks of surgery are complications due to hemorrhage, infection and complications from general anesthesia.

Lung Cancer Radiation

Therapy radiation may be used as a treatment for both NSCLC (non-small-cell lung cancer) and SCLC (small cell lung cancer). Radiation therapy of lung cancer uses high-energy X-rays or other radiation to kill cancer cells from dividing. Radiotherapy may be administered in curative treatment, palliative treatment (using low doses of radiation that have curative regimes), or as adjuvant therapy in combination with surgery or chemotherapy. The radiation is delivered either externally, using a machine that aims radiation at cancer, or internally by placing radioactive material in sealed containers in the area of the body where the tumor is located. Brachytherapy is a term used to describe the use of a small pellet of radioactive material placed directly in cancer or in the air near the cancer. This is usually done through a bronchoscope.

Radiotherapy lung cancer may be given if a person refuses surgery if the tumor has spread to areas such as the lymph nodes or trachea, making surgical removal impossible, or if a person has other conditions that make too sick to go through major surgery. Radiation therapy is usually only reduce the tumor or the limits of its growth when given alone, however, in 10% -15% of people that leads to a long-term remission and palliation of cancer. Combining radiation therapy with chemotherapy may increase survival when given chemotherapy. External radiation therapy, in general, can be performed on an outpatient basis, while internal radiotherapy requires a short hospital stay. A person who has a serious lung disease, in addition to lung cancer may not be able to receive radiotherapy in the lungs. A type of external radiation called “Gamma Knife” is sometimes used to treat brain metastases only. In this procedure, the multiple radiation beams are focused on the tumor for a few minutes to several hours, while the head is held in place by a rigid structure.

For external beam radiation, a process called simulation is necessary before treatment. Using CT, computers and precise measurements, simulation maps the exact location where the radiation is delivered, called the treatment field or port. This process usually takes 30 minutes to two hours. The external radiation therapy in general, it takes four or five days a week for several weeks.

Radiation therapy does not increase risk of major surgery, but can have unpleasant side effects such as fatigue and lack of energy. A small number of white blood cells (making a person more vulnerable to infection) and low levels of platelets in the blood (blood clotting more difficult) can also occur with radiotherapy. If the digestive organs are in the area exposed to radiation, patients may experience nausea, vomiting or diarrhea. Radiotherapy May irritate the skin in that area, but the irritation usually improves with time after treatment.

Lung Cancer Chemotherapy

Both non-small-cell lung cancer (NSCLC) and CPM can be treated with chemotherapy. Chemotherapy refers to the administration of drugs that inhibit the growth of cancerous cells by killing them or preventing them from dividing. Chemotherapy can be administered alone as adjuvant therapy to surgery or in combination with radiotherapy. If a number of chemotherapy drugs have been developed, the drugs of the class of drugs known as platinum have been most effective in the treatment of lung cancer.

Chemotherapy is the treatment of choice for most CPM, because these tumors are very common in the body when diagnosed. Only half of those with SCLC survive for four months without chemotherapy. With chemotherapy, their survival time increased from four to five times. Chemotherapy alone is not particularly effective in the treatment of non-small-cell lung cancer (NSCLC), but when have metastatic NSCLC, it may prolong survival in many cases.

Chemotherapy may be given in pill form as intravenous infusion, or a combination of both. Chemotherapy treatments are usually given on an outpatient basis. A combination of drugs is given in a series of treatments, called cycles for a period of weeks or months, with breaks between cycles. Unfortunately, chemotherapy drugs also kill normal dividing cells in the body, causing unpleasant side effects. Damage to blood cells may cause increased susceptibility to infections and difficulties related to blood coagulation (bleeding or bruising easily). Other side effects include loss, fatigue, weight gain, hair loss, nausea, vomiting, diarrhea and mouth sores. Side effects of chemotherapy depend on the dose and combination of drugs used and can vary from person to person. Drugs have been developed that can treat or prevent many side effects of chemotherapy. Side effects usually disappear during the recovery phase of treatment or after its completion.

Prophylactic cranial irradiation

Small cell lung cancer (SCLC) often spreads to the brain. Sometimes people with SCLC, which responds well to treatment, are treated with radiation to treat quickly spread to the head brain (called micrometastases) is not yet detectable with CT or MRI and no symptoms yet. Brain radiation therapy can cause problems with short-term memory, fatigue, nausea and other side effects.

Treatment of recurrence

Lung cancer that has returned after treatment with surgery, chemotherapy and / or radiation therapy is called recurrent or relapsed. If recurrent cancer is confined to a site in the lungs, can be treated by surgery. Relapsed tumors do not usually respond to chemotherapy drugs administered previously. As platinum-based drugs are generally used in the initial chemotherapy of lung cancer, these drugs are not useful in most cases of recurrence. A type of chemotherapy called second-line chemotherapy is used to treat recurrent cancer previously treated with chemotherapy, and a series of second-line chemotherapy have proven effective in prolonging survival. People with lung cancer are quite recurrent to tolerate the treatment are also good candidates for experimental therapies (see below), including clinical trials.

Targeted therapy

An alternative to standard chemotherapy is the drug erlotinib (Tarceva), which can be used in patients with ( NSCLC non-small-cell lung cancer ) who no longer respond to chemotherapy. Specific call is a drug, a drug that specifically target cancer cells, causing less damage to normal cells. Erlotinib targets a receptor protein called epidermal growth factor (EGFR), which helps cells to divide. This protein is found in abnormally high levels on the surface of certain types of cancer cells, including many cases of non-small cell cancer of lung cells. Erlotinib is taken orally as tablets.

Among other efforts targeted therapy known as the fight against drugs that block angiogenesis, the development of new blood vessels in cancer. Without blood vessels that carry oxygenated blood adequate cancer cells to die. Anti-angiogenic drug bevacizumab (Avastin) has recently been found to prolong survival in lung cancer in advanced stage when added to standard chemotherapy. Bevacizumab is administered intravenously every two to three weeks. However, since this medication may cause bleeding, is not suitable for use in patients who are coughing up blood, if lung cancer has spread to the brain, or those receiving anticoagulant therapy (diluent blood “) drugs. Avastin is also used in cases of squamous cell cancer, because it causes bleeding of this type of lung cancer.

Photodynamic therapy (PDT)

Therapy newer used for different types and stages of lung cancer (and some other cancers) is photodynamic therapy. In photodynamic therapy, an agent of photosynthesis (as a porphyrin, a naturally occurring substance in the body) is injected into the bloodstream of a couple of hours before surgery. Meanwhile, the deposition agent itself selectively in rapidly growing cells like cancer cells. Then follows a procedure in which the physician applies a certain wavelength of light through a handheld wand directly to the site of the cancer and surrounding tissues. Light energy activates the photosensitizing agent, causing the production of a toxin that kills tumor cells. PDT has the advantage to precisely target the cancer site, is less invasive than surgery and can be repeated on the same site if necessary. The disadvantages of PDT is that it is only useful in the treatment of cancers that can be achieved with a light source and is not suitable for the treatment of cancer spread. The investigation is ongoing to determine the effectiveness of photodynamic therapy in lung cancer.

Radio Frequency Ablation (RFA)

Radiofrequency ablation is studied as an alternative to surgery, especially in cases of lung cancer early. In this new type of treatment involves inserting a needle through skin cancer, usually under the direction of TC. Radiofrequency (electrical) energy is transmitted to the tip of the needle where it produces heat in the tissues, killing the cancerous tissue and the closure of small blood vessels that cancer feed. RFA is usually not painful and has been approved by the Food and Drug Administration of the United States to treat certain types of cancers including lung cancer. Studies have shown that this treatment may prolong survival similar to surgery, when used to treat early stage lung cancer, but without the risks of major surgery and prolonged recovery time associated with major surgical procedures .

The experimental treatments

As no treatment is currently available that is very effective in treating lung cancer, patients can offer a range of treatments that are still being tested, which means that doctors have not yet sufficiently d ‘information to decide if these treatments must be accepted forms of treatment for lung cancer. New drugs or new combinations of drugs are tested in the so-called clinical trials, which are studies that evaluate the effectiveness of new drugs, compared with treatments that are already widely used. Experimental treatment known as immunotherapy, are being considered that involve the use of vaccine-related therapies or other therapies that seek to use the body’s immune system to fight cancer cells.

Incoming Search Terms :

Causes of Lung Cancer Information

Maybe some people ask, what causes of lung cancer?  There are many lung cancer causes, such as smoking or to be passive smokers, asbestos fibers, because radon, or the family predisposition, lung disease from family, air pollution or history of the lung cancer family can make lung cancer cause (lungenkrebs verursacht, provoque le cancer du poumon, provoca il cancro ai polmoni, causa cáncer de pulmón).

Smoking

The incidence of lung cancer is closely linked to smoking, with approximately 90% of lung cancers caused by snuff. The risk of lung cancer increases with the number of cigarettes smoked over time, doctors refer to this risk in terms of pack-years history of smoking (number of packs of cigarettes smoked per day multiplied by the number of years). For example, a person who has smoked two packs of cigarettes a day for 10 years has a pack of 20, smoking history year. Although the risk of lung cancer increases even with a 10 pack year history of smoking, those who have stories 30-lot-of one year or more are regarded as having the greatest risk of developing lung cancer. Among people who smoke two or more packs of cigarettes a day, seven people who die from lung cancer.

Pipe and cigar smoking can also cause lung cancer, but the risk is not as high as with cigarette smoking. As a person who smokes a pack of cigarettes per day had a risk of developing lung cancer is 25 times higher than a non-smoker, pipe smokers and cigar has a risk of lung cancer is about five times the non – smoking.

Snuff smoke contains over 4,000 chemical compounds, many of which have been shown to cause cancer, or cancer. The two major carcinogens in tobacco smoke are chemicals known as nitrosamines and polycyclic aromatic hydrocarbons. The risk of developing lung cancer decreases each year after quitting, as normal growth of cells and replace damaged cells in the lungs. In former smokers, the risk of developing lung cancer begins to approach that of a non-smoker for 15 years after quitting.

Passive smoking

Passive smoking, or inhaling the smoke of smokers suck life and work of shared premises, is also a risk factor for developing lung cancer. Research has shown that non-smokers living with a smoker have a 24% increase in risk of developing lung cancer compared to other non-smokers. It is estimated that 3,000 deaths from lung cancer occur each year in the United States that are attributable to passive smoking.

Asbestos fibers

Asbestos fibers are silicate fibers that can persist throughout life in lung tissue after exposure to asbestos. The workplace is a common source of exposure to asbestos fibers, asbestos was widely used in the past that the thermal and acoustic insulation. Today, the use of asbestos is restricted or prohibited in many countries including the United States both lung cancer and mesothelioma (cancer of the pleura, the lung and the lining of the cavity abdominal peritoneum) are associated with exposure to asbestos. Smoking greatly increases the likelihood of developing lung cancer linked to asbestos-exposed workers. Asbestos workers who smoke have a fivefold risk of developing lung cancer than non-smokers and asbestos workers who smoke have a risk that is 50 to 90 times higher than non smoking.

Radon

Radon is a gas, chemically inert gas that is produced by the natural decay of uranium. Uranium decays to form products, including radon, which emit a type of ionizing radiation. Radon is a known cause of lung cancer, and about 12% of deaths from lung cancer attributable to radon, or 15,000-22,000 deaths from lung cancer each year in the United States, making that radon the second leading cause of lung cancers in the U.S. As with exposure to asbestos, smoking increases concomitantly the risk of lung cancer from exposure to radon. Radon gas can travel through soil and enter homes through cracks in the foundations, drains, sewers or other openings. The United States Environmental Protection Agency estimates that one in 15 homes in the U.S. contain dangerous levels of radon gas. Radon is invisible and odorless, but can be detected with simple test kits.

The Familial predisposition

Although most lung cancers are associated with the consumption of tobacco and snuff, the fact that not all smokers eventually develop lung cancer suggests that other factors such as individual genetic predisposition may play a role in the the etiology of lung cancer. Many studies have shown that lung cancer is more likely to occur in smokers and nonsmokers of the family of those who have lung cancer than the general population. Recent research has identified a region on the long (q) arm of chromosome 6, which may contain a gene that confers a greater susceptibility to develop lung cancer in smokers.

Lung diseases

The presence of certain lung diseases, including chronic obstructive pulmonary disease (COPD) is associated with increased risk (four to six times the risk of a non-smoker) to develop lung cancer, even after the concomitant effects tobacco are excluded.

History of lung cancer

Survivors of lung cancer are more at risk than the general population to develop lung cancer second. Survivors of cancers of small cell lung (NSCLC see below) have an additional risk of 1% -2% per year to develop lung cancer second. Among survivors of non-lung cancer, small cell (CPM, see below), the risk of developing certain cancers secondary approaches 6% annually.

Air pollution

Air pollution from power plants, vehicles and industry can increase the likelihood of developing lung cancer among exposed individuals. Up to 1% of deaths from lung cancer are due to inhalation of contaminated air, and experts believe that prolonged exposure to highly polluted air may pose a risk of developing lung cancer similar to that of passive smoking.

Incoming Search Terms :